Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: (I), in which each of variables R1, R2, R3, R4, R5, A1, A2, A3, A4, X and Y is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.

Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof, in which each of variables R1, R2, L, and Z is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.

Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof, in which each of variables R1, R2, L, and Z is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.

Abstract: Disclosed are compounds of formula (I) below and pharmaceutically acceptable salts thereof: (I), in which each of variables R1, R2, R3, R4, R5, A1, A2, A3, A4, X and Y is defined herein. Also disclosed are methods for reducing the glycemic level and treating glucagon-associated disorders with a compound of formula (I) or a salt thereof and a pharmaceutical composition containing same.

Abstract: The present disclosure illustrates a bidirectional wireless charging device. The bidirectional wireless charging device comprises a transceiver chip which is configured to receive a switch signal. The transceiver chip comprises a power stage circuit and a control module. The power stage circuit is coupled to a coil, and the control module is coupled to the power stage circuit. The power stage circuit is configured to output a voltage to the coil, or to receive an induced voltage from the coil. The control module is configured to control the transceiver chip to enter a power mode or a charging mode based upon the switch signal. When the transceiver chip enters the power mode, the transceiver chip provides the voltage to the coil. When the transceiver chip enters the charging mode, the transceiver chip receives the induced voltage from the coil and charges a power storage unit.

Abstract: The present disclosure illustrates a bidirectional wireless charging device. The bidirectional wireless charging device comprises a transceiver chip which is configured to receive a switch signal. The transceiver chip comprises a power stage circuit and a control module. The power stage circuit is coupled to a coil, and the control module is coupled to the power stage circuit. The power stage circuit is configured to output a voltage to the coil, or to receive an induced voltage from the coil. The control module is configured to control the transceiver chip to enter a power mode or a charging mode based upon the switch signal. When the transceiver chip enters the power mode, the transceiver chip provides the voltage to the coil. When the transceiver chip enters the charging mode, the transceiver chip receives the induced voltage from the coil and charges a power storage unit.

Abstract: This invention relates to a method of inhibiting NO production and TNF? and treating coronaviral infection by administering an effective amount of a compound of the following formula: wherein R1, R2, R3, R4, R5, A, and X are as defined herein.